Skip to main content

Table 2 Market size of the global cancer molecular diagnostics by cancer type (Unit: million $) [7]

From: The market trend analysis and prospects of cancer molecular diagnostics kits

Category / Year

2013

2014

2015

2016

2017

2018

2019

CAGR

Breast cancer

375.4

383.8

531.3

735.5

1018.2

1409.5

1951.2

38.4%

Colorectal cancer

346.5

391.6

531.1

720.4

977.1

1325.2

1797.4

35.6%

Cervical cancer

259.0

267.6

304.1

345.5

392.6

446.2

507.0

13.6%

Lung cancer

113.6

128.2

197.0

302.8

465.5

715.4

1099.6

53.7%

Precancer

104.5

124.9

188.3

283.7

427.7

644.6

971.5

50.7%

Prostate cancer

99.2

117.2

170.1

247.0

358.6

520.6

755.8

45.2%

Melanoma

92.0

104.8

134.6

172.8

221.8

284.8

365.7

28.4%

Leukemia

74.5

88.3

130.4

192.6

284.4

419.9

620.1

47.7%

Lymphoma

42.9

51.9

91.0

159.6

279.8

490.7

860.4

75.4%

Pancreatic cancer

26.4

32.7

47.0

67.6

97.1

139.6

200.6

43.7%

Bladder cancer

21.2

25.9

36.4

51.3

72.2

101.6

142.9

40.7%

Chest cancer

19.1

21.8

35.3

57.3

92.9

150.7

244.3

62.1%

Brain cancer

18.4

24.2

34.2

48.3

68.3

96.5

136.4

41.3%

Thyroid cancer

12.6

16.3

28.2

48.9

84.7

146.6

253.9

73.2%

Kidney cancer

11.7

15.6

27.6

49.0

86.8

153.9

272.8

77.2%

Ovarian cancer

6.7

9.5

16.4

28.3

49.0

84.6

146.1

72.7%

Stomach cancer

0.0

3.6

7.9

17.2

37.5

81.9

178.8

118.4%

Other

      

157.8

 

Total

1623.7

1807.9

2511.1

3527.8

5014.1

7212.2

10,662.3

42.6%